S
Sally She-Ting Shu
Researcher at The Chinese University of Hong Kong
Publications - 18
Citations - 1465
Sally She-Ting Shu is an academic researcher from The Chinese University of Hong Kong. The author has contributed to research in topics: Fatty liver & Transient elastography. The author has an hindex of 12, co-authored 18 publications receiving 841 citations.
Papers
More filters
Journal ArticleDOI
Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study
Raymond Kwok,Kai Chow Choi,Grace Lai-Hung Wong,Yuying Zhang,Henry Lik-Yuen Chan,Andrea O.Y. Luk,Sally She-Ting Shu,Anthony W.H. Chan,Ming-Wai Yeung,Juliana C.N. Chan,Alice P.S. Kong,Vincent Wai-Sun Wong +11 more
TL;DR: The data support screening for NAFLD and/or advanced fibrosis in patients with type 2 diabetes, and those with obesity and dyslipidaemia are at particularly high risk and may be the target for liver assessment.
Journal ArticleDOI
Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients.
Jonathan Chung-Fai Leung,Thomson Chi-Wang Loong,Jeremy Lok Wei,Grace Lai-Hung Wong,Anthony W.H. Chan,Paul Cheung-Lung Choi,Sally She-Ting Shu,Angel Mei-Ling Chim,Henry Lik-Yuen Chan,Vincent Wai-Sun Wong +9 more
TL;DR: Nonobese NAFLD patients tend to have less‐severe disease and may have a better prognosis than obese patients and Hypertriglyceridemia and higher creatinine are the key factors associated with advanced liver disease in nonobese patients.
Journal ArticleDOI
Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.
Vincent Wai-Sun Wong,Grace Lai-Hung Wong,Ruth Chan,Sally She-Ting Shu,Bernice Ho-Ki Cheung,Liz Li,Angel Mei-Ling Chim,Carmen Ka-Man Chan,J. Leung,Winnie C.W. Chu,Jean Woo,Henry Lik-Yuen Chan +11 more
TL;DR: It is shown that remission of NAFLD can be achieved in 67% of non-obese patients after lifestyle intervention, which is more likely than obese patients to maintain weight reduction and normal liver enzymes in the long run.
Journal ArticleDOI
Impact of the New Definition of Metabolic Associated Fatty Liver Disease on the Epidemiology of the Disease.
Vincent Wai-Sun Wong,Grace Lai-Hung Wong,Jean Woo,Jill Abrigo,Carmen Ka-Man Chan,Sally She-Ting Shu,J. Leung,Angel Mei-Ling Chim,Alice P.S. Kong,Grace Lui,Henry Lik-Yuen Chan,Winnie C.W. Chu +11 more
TL;DR: The new definition of MAFLD does not significantly change the prevalence compared with NAFLD, but it may reduce the incidence by 25%.
Journal ArticleDOI
Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease.
Vincent Wai-Sun Wong,Marie Irles,Grace Lai-Hung Wong,Sarah Shili,Anthony W.H. Chan,Wassil Merrouche,Sally She-Ting Shu,Juliette Foucher,Brigitte Le Bail,Wah-Kheong Chan,Henry Lik-Yuen Chan,Victor de Ledinghen +11 more
TL;DR: High BMI but not severe steatosis increases LSM, and the same LSM cut-offs can be used without further adjustment for ste atosis when M and XL probes are used according to the appropriate BMI.